Related Experiment Video
Updated: Jul 9, 2026
06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
TLR2 in murine atherosclerosis
Peter S Tobias1, Linda K Curtiss
1Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA. tobias@scripps.edu
Seminars in Immunopathology
|December 7, 2007
Summary
Inflammation, not just lipid buildup, drives atherosclerosis. This study investigated the role of Toll-like receptors (TLRs), particularly TLR2, in mouse models of this cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Immunology
- Molecular Biology
Background:
- Atherosclerosis pathogenesis is complex, involving both lipid accumulation and inflammatory processes.
- The role of pattern recognition receptors, such as Toll-like receptors (TLRs), in atherosclerosis is increasingly recognized.
Purpose of the Study:
- To investigate the specific roles of Toll-like receptors (TLRs), with a focus on TLR2, in the development of atherosclerosis.
- To elucidate the contribution of TLR-mediated inflammation to atherosclerotic plaque formation in a murine model.
Main Methods:
- Utilized established murine models of atherosclerosis.
- Employed techniques to assess TLR expression and activation within the vessel wall.
- Analyzed atherosclerotic lesion development and inflammatory markers.
Main Results:
- Demonstrated significant involvement of TLRs, particularly TLR2, in the progression of atherosclerosis.
- Identified specific inflammatory pathways mediated by TLR2 that contribute to disease development.
- Quantified the impact of TLR2 on lipid accumulation and plaque characteristics.
Conclusions:
- TLR2 plays a critical role in driving inflammatory responses that promote atherosclerosis.
- Targeting TLR2 may offer a novel therapeutic strategy for managing atherosclerosis.
- Inflammation, mediated by TLRs, is a key driver of atherosclerosis, extending beyond simple lipid accumulation.
